�����ƽ��

Adoptive T cell therapy is a rapidly progressing field that leverages the abilities of T cells to recognize and eliminate diseased cells, with applications spanning cancer immunotherapy and emerging treatments for autoimmune and infectious diseases. See MoreThe development of these therapies requires precise control over T cell isolation, activation, expansion, and genetic modification, while maintaining functionality and phenotype. Variability in donor material and increasing manufacturing demands continue to present challenges across development and translation.

In cell therapy workflows, T cells must be reliably expanded and engineered while preserving potency, viability, and key phenotypic characteristics. In vitro systems support optimization of activation conditions, expansion strategies, and functional outputs such as cytokine production and cytotoxicity. Scalable, standardized approaches are essential for supporting CAR T cell production and other engineered T cell applications.

By integrating well-defined T cell processing tools and reagents into your workflow, you can improve reproducibility and streamline development.